Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1573-0646
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia ; volume:32 ; number:3 ; day:20 ; month:12 ; year:2013 ; pages:489-499 ; date:6.2014
Investigational new drugs ; 32, Heft 3 (20.12.2013), 489-499, 6.2014

Creator
Kelly, Kevin R.
Shea, Thomas C.
Goy, André
Berdeja, Jesus G.
Reeder, Craig B.
McDonagh, Kevin T.
Zhou, Xiaofei
Danaee, Hadi
Liu, Hua
Ecsedy, Jeffrey A.
Niu, Huifeng
Benaim, Ely
Padmanabhan Iyer, Swaminathan
Contributor
SpringerLink (Online service)

DOI
10.1007/s10637-013-0050-9
URN
urn:nbn:de:101:1-2019080220211072936077
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Kelly, Kevin R.
  • Shea, Thomas C.
  • Goy, André
  • Berdeja, Jesus G.
  • Reeder, Craig B.
  • McDonagh, Kevin T.
  • Zhou, Xiaofei
  • Danaee, Hadi
  • Liu, Hua
  • Ecsedy, Jeffrey A.
  • Niu, Huifeng
  • Benaim, Ely
  • Padmanabhan Iyer, Swaminathan
  • SpringerLink (Online service)

Other Objects (12)